Baillieu Holst have just put out a BUY recommendation on BPO with a price target of $0.009.
It is actually a pretty good report and very exciting if they can pull off what the company is suggesting they can. It is prfect timing with everyone targeting personal devices for different forms of health analysis and analtics.
A pretty good punt at the current price of $0.003
Baillieu Holst Report
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
